Comment
doi: 10.1016/S2352-3018(17)30017-6.
Epub 2017 Feb 15.
Integrase inhibitors go head-to-head
Affiliations
- PMID: 28219611
- DOI: 10.1016/S2352-3018(17)30017-6
Item in Clipboard
Comment
Integrase inhibitors go head-to-head
Lancet HIV.
2017 Apr.
No abstract available
Comment on
-
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial.Lancet HIV. 2017 Apr;4(4):e154-e160. doi: 10.1016/S2352-3018(17)30016-4. Epub 2017 Feb 15. Lancet HIV. 2017. PMID: 28219610 Clinical Trial.
Similar articles
-
Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.Bioorg Med Chem Lett. 2010 Sep 15;20(18):5469-71. doi: 10.1016/j.bmcl.2010.07.087. Epub 2010 Jul 25. Bioorg Med Chem Lett. 2010. PMID: 20709544
-
Integrase inhibitors in the treatment of HIV-1 infection.J Antimicrob Chemother. 2010 Dec;65(12):2485-8. doi: 10.1093/jac/dkq350. Epub 2010 Sep 18. J Antimicrob Chemother. 2010. PMID: 20852268 Review.
-
The future of integrase inhibitors of HIV-1.Curr Opin Virol. 2012 Oct;2(5):580-7. doi: 10.1016/j.coviro.2012.08.005. Epub 2012 Sep 12. Curr Opin Virol. 2012. PMID: 22980926 Review.
-
Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.Bioorg Med Chem. 2015 Feb 15;23(4):735-41. doi: 10.1016/j.bmc.2014.12.059. Epub 2015 Jan 3. Bioorg Med Chem. 2015. PMID: 25618597
-
Resistance to inhibitors of the human immunodeficiency virus type 1 integration.Braz J Infect Dis. 2010 Sep-Oct;14(5):513-8. Braz J Infect Dis. 2010. PMID: 21221483 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
